With baby KJ successfully receiving the world’s first personalized CRISPR therapy, alongside continued innovation across in vivo and base editing, and rapid ex vivo clinical progress, the genome editing field […]

As 2025 shapes up to be a transformative year for talent acquisition in life sciences, the 7th LEAP TA: Life Sciences returns to Boston, MA this September (29 - October 1), […]

The 9th MASH Drug Development Summit is the definitive meeting for pharma and biotech leaders advancing the next generation of therapies for MASH. With the approval of Rezdiffra signaling a […]